39824 Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 
reduce potential exposure and risk to 
aquatic plant communities from atrazine via runoff from agricultural uses in field corn, sweet corn, sorghum and 
sugarcane. 
TABLE—R EGISTRATION REVIEW FOR PROPOSED REVISIONS TO THE ATRAZINE INTERIM DECISION  
Registration review case name and No. Pesticide docket ID No. Chemical review manager, telephone No., email address 
Atrazine, Case Number 0062 ................. EPA–HQ–OPP–2013–0266 ...... Alex Hazlehurst, (202) 566–2249, Hazlehurst.alexander@epa.gov . 
The registration review docket for a 
pesticide includes earlier documents 
related to the registration review of the case. For example, the review opened with a Summary Document, containing a Preliminary Work Plan, for public comment. A Final Work Plan was placed in the docket following public comment on the initial docket. The documents in the dockets describe EPA’s rationales for conducting additional risk assessments for the registration review of the pesticide included in the table in Unit II.A., as well as the Agency’s subsequent findings and consideration of possible risk mitigation measures. The proposed revisions to the atrazine interim registration review decision are supported by the rationales included in those documents. Following public comment, the Agency will issue the ‘‘Revisions to the Atrazine Interim Registration Review Decision, Case 0062’’ memorandum for products containing atrazine. 
The regulation at 40 CFR 155.58(a) 
provides for a minimum 60-day public comment period on all proposed interim and/or final registration review decisions. This comment period is limited to the proposed revisions to the interim registration review decision. The Agency is not soliciting comment on any other aspects of the atrazine ID other than those specifically identified in the proposed revisions to the atrazine ID memorandum All comments should 
be submitted using the methods in 
ADDRESSES , and must be received by 
EPA on or before the closing date. These comments will become part of the docket for atrazine. Comments received after the close of the comment period will be marked ‘‘late.’’ EPA is not required to consider these late comments. 
The Agency will carefully consider all 
comments related to the proposed revisions to the atrazine ID received by the closing date and will provide a ‘‘Response to Comments Memorandum’’ in the docket. The revisions to the atrazine interim registration review decision memorandum will explain the effect that any comments had on the revisions to the atrazine interim registration review decision and provide the Agency’s response to significant 
comments. 
Background on the registration review 
program is provided at: https://www.epa.gov/pesticide-reevaluation. Links to earlier documents related to the registration review of this pesticide are provided at: https://
www.regulations.gov/docket/EPA-HQ- OPP-2013-0266. 
Authority: 7 U.S.C. 136 et seq. 
Dated: June 23, 2022. 
Mary Reaves, 
Director, Pesticide Re-Evaluation Division, 
Office of Pesticide Programs. 
[FR Doc. 2022–14255 Filed 7–1–22; 8:45 am] 
BILLING CODE 6560–50–P 
ENVIRONMENTAL PROTECTION 
AGENCY 
[EPA–HQ–OPPT–2016–0742 FRL–9946–01– 
OCSPP] 
Methylene Chloride; Draft Revision to 
Toxic Substances Control Act (TSCA) Risk Determination; Notice of Availability and Request for Comment 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Notice. 
SUMMARY : The Environmental Protection 
Agency (EPA) is announcing the availability of and seeking public comment on a draft revision to the risk determination for the methylene chloride risk evaluation issued under TSCA. The draft revision to the methylene chloride risk determination reflects the announced policy changes to ensure the public is protected from unreasonable risks from chemicals in a way that is supported by science and the law. In this draft revision to the risk determination EPA finds that methylene chloride, as a whole chemical substance, presents an unreasonable risk of injury to health when evaluated under its conditions of use. In addition, this revised risk determination does not reflect an assumption that all workers always appropriately wear personal protective equipment (PPE). EPA understands that there could be occupational safety protections in place at workplace locations; however, not assuming use of PPE reflects EPA’s 
recognition that unreasonable risk may exist for subpopulations of workers that may be highly exposed because they are not covered by OSHA standards, or their employers are out of compliance with OSHA standards, or because many of OSHA’s chemical-specific permissible exposure limits largely adopted in the 1970’s are described by OSHA as being ‘‘outdated and inadequate for ensuring protection of worker health,’’ or because the OSHA permissible exposure limit (PEL) alone may be inadequate for ensuring protection of worker health. This revision, when final, would supersede the condition of use-specific no unreasonable risk determinations in the June 2020 methylene chloride risk evaluation (and withdraw the associated order) and would make a revised determination of unreasonable risk for methylene chloride as a whole chemical substance. 
DATES : Comments must be received on 
or before August 4, 2022. 
ADDRESSES : Submit your comments, 
identified by docket identification (ID) number EPA–EPA–HQ–OPPT–2016– 0742, using the Federal eRulemaking Portal at https://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business 
Information (CBI) or other information whose disclosure is restricted by statute. Additional instructions on commenting and visiting the docket, along with more information about dockets generally, is available at https://www.epa.gov/ dockets. 
FOR FURTHER INFORMATION CONTACT : For 
technical information contact: Ingrid Feustel, Office of Pollution Prevention and Toxics (7404M), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–3199; email address: feustel.ingrid@epa.gov. 
For general information contact: The 
TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@epa.gov. 
SUPPLEMENTARY INFORMATION : 
VerDate Sep<11>2014 17:28 Jul 01, 2022 Jkt 256001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\05JYN1.SGM 05JYN1lotter on DSK11XQN23PROD with NOTICES139825 Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 
I. Executive Summary 
A. Does this action apply to me? 
This action is directed to the public 
in general. This action may, however, be 
of interest to those involved in the manufacture, processing, distribution, use, disposal, and/or the assessment of risks involving chemical substances and mixtures. You may be potentially affected by this action if you manufacture (defined under TSCA to include import), process (including recycling), distribute in commerce, use or dispose of methylene chloride, including methylene chloride in products. Since other entities may also be interested in this draft revision to the risk determination, EPA has not attempted to describe all the specific entities that may be affected by this action. 
B. What is EPA’s authority for taking 
this action? 
TSCA section 6, 15 U.S.C. 2605, 
requires EPA to conduct risk evaluations to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment, without consideration of costs or other non-risk factors, including an unreasonable risk to a potentially exposed or susceptible subpopulation (PESS) identified as relevant to the risk evaluation by the Administrator, under the conditions of use. 15 U.S.C. 2605(b)(4)(A). TSCA sections 6(b)(4)(A) through (H) 
enumerate the deadlines and minimum requirements applicable to this process, including provisions that provide instruction on chemical substances that must undergo evaluation, the minimum components of a TSCA risk evaluation, and the timelines for public comment and completion of the risk evaluation. TSCA also requires that EPA operate in a manner that is consistent with the best available science, make decisions based on the weight of the scientific evidence, and consider reasonably available information. 15 U.S.C. 2625(h), (i), and (k). 
The statute identifies the minimum 
components for all chemical substance risk evaluations. For each risk evaluation, EPA must publish a document that outlines the scope of the risk evaluation to be conducted, which includes the hazards, exposures, conditions of use, and the potentially exposed or susceptible subpopulations that EPA expects to consider. 15 U.S.C. 2605(b)(4)(D). The statute further provides that each risk evaluation must also: (1) integrate and assess available information on hazards and exposures for the conditions of use of the chemical substance, including information that is 
relevant to specific risks of injury to health or the environment and information on relevant potentially exposed or susceptible subpopulations; (2) describe whether aggregate or sentinel exposures were considered and the basis for that consideration; (3) take into account, where relevant, the likely duration, intensity, frequency, and number of exposures under the conditions of use; and (4) describe the weight of the scientific evidence for the identified hazards and exposures. 15 U.S.C. 2605(b)(4)(F)(i) through (ii) and (iv) through (v). Each risk evaluation must not consider costs or other non- risk factors. 15 U.S.C. 2605(b)(4)(F)(iii). 
EPA has inherent authority to 
reconsider previous decisions and to revise, replace, or repeal a decision to the extent permitted by law and supported by reasoned explanation. FCC v. Fox Television Stations, Inc., 556 U.S. 
502, 515 (2009); see also Motor Vehicle Mfrs. Ass’n v. State Farm Mutual Auto. 
Ins. Co., 463 U.S. 29, 42 (1983). Further, on July 14, 2021, the Ninth Circuit granted EPA’s motion for voluntary remand without vacatur, so that EPA may conduct reconsideration proceedings on the methylene chloride Risk Evaluation—particularly to reconsider the no unreasonable risk determinations made within. Neighbors for Environmental Justice et al., v. U.S. 
Environmental Protection Agency et al., (9th Cir. No. 20–72091). 
C. What action is EPA taking? 
EPA is announcing the availability of 
and seeking public comment on a draft 
revision to the risk determination for the risk evaluation for methylene chloride under TSCA, which was initially published in June 2020 (Ref. 1). EPA is specifically seeking public comment on the draft revision to the risk determination for the risk evaluation where the Agency intends to determine that methylene chloride, as a whole chemical, presents an unreasonable risk of injury to health when evaluated under its conditions of use. The Agency’s risk determination for methylene chloride is better characterized as a whole chemical risk 
determination rather than condition-of- use-specific risk determinations. Accordingly, EPA would revise and replace section 5 of the risk evaluation for methylene chloride where the findings of unreasonable risk to health were previously made for the individual conditions of use evaluated. EPA would also withdraw the order issued previously for six conditions of use previously determined not to present unreasonable risk. This revision would be consistent 
with EPA’s plans to revise specific 
aspects of the first ten TSCA chemical risk evaluations in order to ensure that the risk evaluations better align with TSCA’s objective of protecting health and the environment. Under the draft revision, removing the assumption that workers always appropriately wear PPE (see Unit II.C.) in making the whole chemical risk determination for methylene chloride would mean that: five additional conditions of use in addition to the original 47 would drive the unreasonable risk determination for methylene chloride; inhalation risks to workers in addition to the previously identified inhalation risk to occupational non-users (ONUs) would drive the unreasonable risk in three conditions of use; and additional risk to workers for acute and chronic non- cancer dermal exposures and for cancer from inhalation exposures would also drive the unreasonable risk in many of those 52 conditions of use (where previously those conditions of use were identified as presenting unreasonable risk only for chronic non-cancer effects and/or for acute effects) (Ref. 2 at pg. 319 provides the risk estimates, and Table 5–1 in the risk determination (Ref. 1) provides information related to the unreasonable risk). Overall, 52 conditions of use out of 53EPA evaluated would drive the methylene chloride whole chemical unreasonable risk determination due to risks identified for human health. The full list of the conditions of use evaluated for the methylene chloride TSCA risk evaluation is in Tables 4–2 and 4–3 of the risk evaluation (Ref. 2). 
D. What should I consider as I prepare 
my comments for EPA? 
1. Submitting CBI. Do not submit this 
information to EPA through regulations.gov or email. Clearly mark 
the part or all of the information that you claim to be CBI. For CBI information in a disk or CD–ROM that you mail to EPA, mark the outside of the disk or CD–ROM as CBI and then identify electronically within the disk or CD–ROM the specific information that 
is claimed CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 
2. Tips for preparing your comments. 
When preparing and submitting your comments, see the commenting tips at 
VerDate Sep<11>2014 17:28 Jul 01, 2022 Jkt 256001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\05JYN1.SGM 05JYN1lotter on DSK11XQN23PROD with NOTICES139826 Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 
https://www.epa.gov/dockets/ 
comments.html. 
II. Background A. Why is EPA re-issuing the risk 
determination for the methylene chloride risk evaluation conducted under TSCA? 
In 2016, as directed by TSCA section 
6(b)(2)(A), EPA chose the first ten chemical substances to undergo risk evaluations under the amended TSCA. These chemical substances are asbestos, 1-bromopropane, carbon tetrachloride, C.I. Pigment Violet 29, HBCD, 1,4- dioxane, methylene chloride, n- methylpyrrolidone (NMP), perchloroethylene (PCE), and trichloroethylene (TCE). 
From June 2020 to January 2021, EPA 
published risk evaluations on the first ten chemical substances, including for methylene chloride in June 2020. The risk evaluations included individual unreasonable risk determinations for each condition of use evaluated. EPA issued determinations that particular conditions of use did not present an unreasonable risk by order under TSCA section 6(i)(1). 
In accordance with Executive Order 
13990 (Ref. 3) and other Administration priorities (Refs. 4, 5, and 6), EPA reviewed the risk evaluations for the first ten chemical substances, including methylene chloride, to ensure that they meet the requirements of TSCA, including conducting decision making in a manner that is consistent with the best available science. 
As a result of this review, EPA 
announced plans to revise specific aspects of the first ten risk evaluations in order to ensure that the risk evaluations appropriately identify unreasonable risks and thereby help ensure the protection of human health and the environment (Ref. 7). To that end, EPA is reconsidering two key aspects of the risk determinations for methylene chloride published in June 2020. First, following a review of specific aspects of the June 2020 methylene chloride risk evaluation, EPA proposes that making an unreasonable risk determination for HBCD as a whole chemical substance, rather than making unreasonable risk determinations separately on each individual condition of use evaluated in the risk evaluation, is the most appropriate approach to HBCD under the statute and implementing regulations. Second, EPA proposes that the risk determination should be explicit that it does not rely on assumptions regarding the use of personal protective equipment (PPE) in making the unreasonable risk determination under TSCA section 6, 
even though some facilities might be using PPE as one means to reduce workers exposures; rather, the use of PPE would be considered during risk management as appropriate. 
Separately, EPA is conducting a 
screening approach to assess potential risks from the air and water pathways for several of the first 10 chemicals, including this chemical. For methylene chloride the exposure pathways that were or could be regulated under another EPA administered statute were excluded from the final risk evaluation (see section 1.4.2 of the June 2020 methylene chloride risk evaluation). This resulted in the surface water, drinking water, ambient air, and sediment pathways for methylene chloride not being assessed for human health exposures or the general population. The goal of the recently- developed screening approach is to remedy this exclusion and to identify if there are risks that were unaccounted for in the methylene chloride risk evaluation. While this analysis is underway, EPA is not incorporating the screening-level approach into this draft revised unreasonable risk determination. If the results suggest there is additional risk, EPA will determine if the risk management approaches being contemplated for methylene chloride will protect against these risks or if the risk evaluation will need to be formally supplemented or revised. 
This action pertains only to the risk 
determination for methylene chloride. While EPA intends to consider and may take additional similar actions on other of the first ten chemicals, EPA is taking a chemical-specific approach to reviewing the risk evaluations and is incorporating new policy direction in a 
surgical manner, while being mindful of the Congressional direction on the need to complete risk evaluations and move toward any associated risk management activities in accordance with statutory deadlines. 
B. What is a whole chemical view of the 
unreasonable risk determination for the methylene chloride risk evaluation? 
TSCA section 6 repeatedly refers to 
determining whether a chemical substance presents unreasonable risk 
under its conditions of use. Stakeholders have disagreed over whether a chemical substance should receive: A single determination that is comprehensive for the chemical substance after considering the conditions of use, referred to as a whole- chemical determination; or multiple determinations, each of which is specific to a condition of use, referred 
to as condition-of-use-specific determinations. 
The proposed risk evaluation 
procedural rule was premised on the whole chemical approach to making an unreasonable risk determination (Ref. 8). In that proposed rule, EPA acknowledged a lack of specificity in statutory text that might lead to different views about whether the statute compelled EPA’s risk evaluations to address all conditions of use of a chemical substance or whether EPA had discretion to evaluate some subset of conditions of use (i.e., to scope out some 
manufacturing, processing, distribution in commerce, use, or disposal activities), but also stated that ‘‘EPA believes the word ‘the’ (in TSCA section 6(b)(4)(A)) is best interpreted as calling for evaluation that considers all conditions of use.’’ (Ref. 8). 
The proposed rule, however, was 
unambiguous on the point that an unreasonable risk determination would be for the chemical substance as a whole, even if based on a subset of uses. (See Ref. 8 at pgs. 7565–66: ‘‘TSCA section 6(b)(4)(A) specifies that a risk evaluation must determine whether ‘a chemical substance’ presents an unreasonable risk of injury to health or the environment ‘under the conditions of use.’ The evaluation is on the chemical substance—not individual conditions of use—and it must be based on ‘the conditions of use.’ In this context, EPA believes the word ‘the’ is best interpreted as calling for evaluation that considers all conditions of use.’’). In the proposed regulatory text, EPA proposed to determine whether the chemical substance presents an unreasonable risk of injury to health or the environment under the conditions of use (Ref. 8 at pg. 7480). 
The final risk evaluation procedural 
rule (Ref. 9) stated: ‘‘As part of the risk evaluation, EPA will determine whether the chemical substance presents an unreasonable risk of injury to health or the environment under each condition of uses [sic] within the scope of the risk evaluation, either in a single decision document or in multiple decision documents.’’ (See also 40 CFR 702.47). For the unreasonable risk determinations in the first ten risk evaluations, EPA applied this provision 
by making individual risk determinations for each condition of use evaluated in each risk evaluation (i.e., the condition-of-use-specific approach to risk determinations). That approach was based on one particular passage in the preamble to the final risk evaluation procedural rule, which stated that EPA will make individual risk 
VerDate Sep<11>2014 17:28 Jul 01, 2022 Jkt 256001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\05JYN1.SGM 05JYN1lotter on DSK11XQN23PROD with NOTICES139827 Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 
determinations for all conditions of use 
identified in the scope. (Ref. 9 at pg. 33744). 
In contrast to this portion of the 
preamble of the final risk evaluation procedural rule, the regulatory text itself and other statements in the preamble reference a risk determination for the chemical substance under its conditions of use, rather than separate risk determinations for each of the conditions of use of a chemical substance. In the key regulatory provision excerpted earlier from 40 CFR 702.47, the text explains that ‘‘[a]s part of the risk evaluation, EPA will determine whether the chemical substance presents an unreasonable risk 
of injury to health or the environment under each condition of uses [sic] within the scope of the risk evaluation, either in a single decision document or in multiple decision documents’’ (Ref. 9, emphasis added). Other language reiterates this perspective. For example, 40 CFR 702.31(a) states that the purpose of the rule is to establish the EPA process for conducting a risk evaluation to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment as required under TSCA section 6(b)(4)(B). Likewise, there are recurring references to whether the chemical substance presents an unreasonable risk in 40 CFR 702.41(a). See, for example, 40 CFR 702.41(a)(6), which explains that the extent to which EPA will refine its evaluations for one or more condition of use in any risk evaluation will vary as necessary to determine whether a chemical substance presents an unreasonable risk. Notwithstanding the one preambular statement about condition-of-use-specific risk determinations, the preamble to the final rule also contains support for a risk determination on the chemical substance as a whole. In discussing the identification of the conditions of use of a chemical substance, the preamble notes that this task inevitably involves the exercise of discretion on EPA’s part, and ‘‘as EPA interprets the statute, the Agency is to exercise that discretion consistent with the objective of conducting a technically sound, manageable evaluation to determine whether a chemical substance—not just individual uses or activities—presents an unreasonable risk.’’ (Ref. 8 at pg. 33729). 
Therefore, notwithstanding EPA’s 
choice to issue condition-of-use-specific risk determinations to date, EPA interprets its risk evaluation regulation to also allow the Agency to issue whole- 
chemical risk determinations. Either approach is permissible under the regulation. A panel of the Ninth Circuit 
Court of Appeals also recognized the ambiguity of the regulation on this point. Safer Chemicals v. EPA, 943 F.3d 
397, 413 (9th Cir. 2019) (holding a challenge about ‘‘use-by-use risk evaluations [was] not justiciable because it is not clear, due to the ambiguous text of the Risk Evaluation Rule, whether the Agency will actually conduct risk evaluations in the manner Petitioners fear’’). 
EPA plans to consider the appropriate 
approach for each chemical substance risk evaluation on a case-by-case basis, taking into account considerations relevant to the specific chemical substance in light of the Agency’s obligations under TSCA. The Agency expects that this case-by-case approach will provide greater flexibility in the Agency’s ability to evaluate and manage unreasonable risk from individual chemical substances. EPA believes this is a reasonable approach under TSCA and the Agency’s implementing regulations. 
With regard to the specific 
circumstances of methylene chloride, as further explained in this notice, EPA proposes that a whole chemical approach is appropriate for methylene chloride in order to protect health and the environment. The whole chemical approach is appropriate for methylene chloride because there are benchmark exceedances for multiple conditions of use (spanning across most aspects of the chemical lifecycle—from manufacturing (including import), processing, commercial and industrial use, consumer use, and disposal) for health of workers, occupational non-users, consumers, and bystanders, and the irreversible health effects (specifically cancer, coma, hypoxia, and death) associated with methylene chloride exposures. Because these chemical- specific properties cut across the conditions of use within the scope of the risk evaluation, a substantial amount of the conditions of use drive the unreasonable risk; therefore, it is appropriate for the Agency to make a determination for methylene chloride that the whole chemical presents an unreasonable risk. 
As explained later in this document, 
the revisions to the unreasonable risk determination (section 5 of the risk 
evaluation) would be based on the existing risk characterization section of the risk evaluation (section 4 of the risk evaluation) and would not involve additional technical or scientific analysis. The discussion of the issues presented in this Federal Register notice and in the accompanying draft revision to the risk determination would supersede any conflicting statements in 
the prior methylene chloride risk evaluation and the response to comments document (Ref. 10). With respect to the methylene chloride risk evaluation, EPA intends to change the risk determination to a whole chemical approach without considering the use of PPE and does not intend to amend, nor does a whole chemical approach require amending, the underlying scientific analysis of the risk evaluation in the risk characterization section of the risk evaluation. EPA views the peer reviewed hazard and exposure assessments and associated risk characterization as robust and upholding the standards of best available science and weight of the scientific evidence per TSCA sections 26(h) and (i). 
EPA is announcing the availability of 
and seeking public comment on the draft superseding unreasonable risk determination for methylene chloride, including a description of the risks driving the unreasonable risk determination under the conditions of use for the chemical substance as a whole. For purposes of TSCA section 6(i), EPA is making a draft risk determination on methylene chloride as a whole chemical. Under the proposed revised approach, the ‘‘whole chemical risk determination for methylene chloride would supersede the no unreasonable risk determinations for methylene chloride that were premised on a condition-of-use-specific approach to determining unreasonable risk. When finalized, EPA’s revised unreasonable risk determination would also contain an order withdrawing the TSCA section 6(i)(1) order in section 5.4.1 of the June 2020 methylene chloride risk evaluation. The draft revision to the risk determination would clarify that EPA does not rely on the assumed use of PPE when making the risk determination for the whole substance. EPA is requesting comment on this potential change. 
C. What revision does EPA propose 
about the use of PPE for the methylene chloride risk evaluation? 
In the risk evaluations for the first ten 
chemical substances, as part of the 
unreasonable risk determination, EPA assumed for several conditions of use that all workers were provided and always used PPE in a manner that achieves the stated assigned protection factor (APF) for respiratory protection or used impervious gloves for dermal protection. In support of this assumption, EPA considered reasonably available information such as public comments indicating that some employers, particularly in the industrial 
VerDate Sep<11>2014 17:28 Jul 01, 2022 Jkt 256001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\05JYN1.SGM 05JYN1lotter on DSK11XQN23PROD with NOTICES139828 Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 
setting, provide PPE to their employees 
and follow established worker protection standards (e.g., Occupational 
Safety and Health Administration (OSHA) requirements for protection of workers, specifically the existing OSHA standard for methylene chloride at 29 CFR 1910.1052). 
For the June 2020 methylene chloride 
risk evaluation, EPA assumed based on reasonably available information, including public comment and safety data sheets, for methylene chloride that workers use PPE—specifically, respirators with an APF 25 to 50—for 26 occupational conditions of use and gloves with PF 10 or 20 for 39 occupational conditions of use. However, in the June 2020 methylene chloride risk evaluation, EPA determined that there was unreasonable risk to workers for 32 of those conditions of use. Overall, EPA determined that 36 of the 41 occupational COUs present unreasonable risks to workers or occupational non-users. 
EPA is revising the assumption for 
methylene chloride that workers always or properly use PPE, although it does not question the information received regarding the occupational safety practices often followed by industry respondents, including as part of compliance with the OSHA methylene chloride standard. Notwithstanding that standard, when characterizing the risk to human health from occupational exposures during risk evaluation under TSCA, EPA believes it is appropriate to evaluate the levels of risk present in baseline scenarios where PPE is not assumed to be used by workers. This approach of not assuming PPE use by workers considers the risk to potentially exposed or susceptible subpopulations (workers and occupational non-users) who may not be covered by OSHA standards, such as self-employed individuals and public sector workers who are not covered by a State Plan. It should be noted that, in some cases, baseline conditions may reflect certain mitigation measures, such as engineering controls, in instances where exposure estimates are based on monitoring data at facilities that have engineering controls in place. 
In addition, EPA believes it is 
appropriate to evaluate the levels of risk 
present in scenarios considering applicable OSHA requirements (e.g., chemical-specific permissible exposure limits (PELs) and/or chemical-specific PELs with additional substance-specific standards) as well as scenarios considering industry or sector best practices for industrial hygiene that are clearly articulated to the Agency. Consistent with this approach, the June 
2020 methylene chloride risk evaluation characterized risk to workers both with and without the use of PPE. By characterizing risks using scenarios that reflect different levels of mitigation, EPA risk evaluations can help inform potential risk management actions by providing information that could be used during risk management to tailor risk mitigation appropriately to address any unreasonable risk identified, or to ensure that applicable OSHA requirements or industry or sector best practices that address the unreasonable risk are required for all potentially exposed or susceptible subpopulations (including self-employed individuals and public sector workers who are not covered by an OSHA State Plan). 
When undertaking unreasonable risk 
determinations as part of TSCA risk evaluations, however, EPA does not believe it is appropriate to assume as a general matter that an applicable OSHA requirement or industry practices related to PPE use is consistently and always properly applied. Mitigation scenarios included in the EPA risk evaluation (e.g., scenarios considering 
use of various PPE) likely represent what is happening already in some facilities. However, the Agency cannot assume that all facilities have adopted these practices for the purposes of making the TSCA risk determination. 
Therefore, EPA proposes to make its 
determination of unreasonable risk for methylene chloride from a baseline scenario that does not assume compliance with OSHA standards, including any applicable exposure limits or requirements for use of respiratory protection or other PPE. Making unreasonable risk determinations based on the baseline scenario should not be viewed as an indication that EPA believes there are no occupational safety protections in place at any location, or that there is widespread non-compliance with applicable OSHA standards. Rather, it reflects EPA’s recognition that unreasonable risk may exist for subpopulations of workers that may be highly exposed because they are not covered by OSHA standards, such as self-employed individuals and public sector workers who are not covered by a State Plan, or because their employer is out of compliance with OSHA standards, or because many of OSHA’s chemical-specific permissible exposure limits largely adopted in the 1970’s are described by OSHA as being ‘‘outdated and inadequate for ensuring protection of worker health,’’ (Ref. 11) or because 
the OSHA Permissible Exposure Limit alone may be inadequate to protect worker health, or because EPA finds 
unreasonable risk for purposes of TSCA notwithstanding OSHA requirements. 
In accordance with this approach, 
EPA is proposing the draft revision to the methylene chloride risk determination without relying on assumptions regarding the occupational use of PPE in making the unreasonable risk determination under TSCA section 6; rather, information on the use of PPE as a means of mitigating risk (including information received from industry respondents about occupational safety practices in use) would be considered during the risk management phase as appropriate. This would represent a change from the approach taken in the 2020 risk evaluation for methylene chloride and EPA invites comments on this draft change to the methylene chloride risk determination. As a general matter, when undertaking risk management actions, EPA intends to strive for consistency with applicable OSHA requirements and industry best practices, including appropriate application of the hierarchy of controls, when those measures would address an identified unreasonable risk including unreasonable risk to potentially exposed or susceptible subpopulations. Consistent with TSCA section 9(d), EPA will consult and coordinate TSCA activities with OSHA and other relevant Federal agencies for the purpose of achieving the maximum applicability of TSCA while avoiding the imposition of duplicative requirements. Informed by the mitigation scenarios and information gathered during the risk evaluation and risk management process, the Agency might propose rules that require risk management practices that may be already common practice in many or most facilities. Adopting clear, comprehensive regulatory standards will foster compliance across all facilities (ensuring a level playing field) and assure protections for all affected workers, especially in cases where current OSHA standards may not apply or be sufficient to address the unreasonable risk. 
Removing the assumptions that 
workers always and appropriately wear PPE in making the whole chemical risk determination for methylene chloride would add five additional conditions of use to the original 47 conditions of use that would drive EPA’s unreasonable risk determination for methylene chloride as a whole chemical. The five conditions of use affected by this change are: manufacturing (domestic manufacture); processing as a reactant; processing: recycling; industrial and 
commercial use as laboratory chemical; and disposal. Additionally, removing 
VerDate Sep<11>2014 17:28 Jul 01, 2022 Jkt 256001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\05JYN1.SGM 05JYN1lotter on DSK11XQN23PROD with NOTICES139829 Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 
this assumption would add inhalation 
risks to workers in addition to the previously identified inhalation risk to occupational non-users as driving the unreasonable risk in three conditions of use and would add risks to workers for acute and chronic non-cancer dermal exposures and for cancer from inhalation exposures as driving the unreasonable risk in many conditions of use (Ref. 2 at pg. 319 provides the risk estimates, and Table 5–1 in the risk determination (Ref. 1) provides information related to the unreasonable risk). 
D. What is methylene chloride? 
Methylene chloride, which is also 
called dichloromethane, is a volatile 
chemical that is produced and imported into the United States, with use estimated at over 260 million pounds per year. It is a solvent used in a variety of industries and applications, such as adhesives, paint and coating products, metal cleaning, chemical processing, and aerosols. In addition, it is used as a propellent, processing aid, or functional fluid in the manufacturing of other chemicals. A variety of consumer and commercial products use methylene chloride as a solvent including sealants, automotive products, and paint and coating removers. Methylene chloride is subject to federal and state regulations and reporting requirements. 
E. What conclusions did EPA reach 
about the risks of methylene chloride in the 2020 TSCA risk evaluation and what conclusions is EPA proposing to reach based on the whole chemical approach and not assuming the use of PPE? 
In the 2020 risk evaluation, EPA 
determined that methylene chloride presents an unreasonable risk to health under the following conditions of use: 
•Manufacture (import); 
•Processing into a formulation, 
mixture, or reaction product; 
•Repackaging; 
•Industrial and commercial use as 
solvent for batch vapor degreasing; 
•Industrial and commercial use as 
solvent for in-line vapor degreasing; 
•Industrial and commercial use as 
solvent for cold cleaning; 
•and commercial use as a solvent for 
aerosol spray degreasers/cleaners; 
•Industrial and commercial use in 
adhesives, sealants, and caulks; 
•Industrial and commercial use in 
paints and coatings; 
•Industrial and commercial use in 
paint and coating removers; 
•Industrial and commercial use in 
adhesive and caulk removers; 
•Industrial and commercial use as 
metal aerosol degreasers; •Industrial and commercial use in 
metal non-aerosol degreasers; 
•Industrial and commercial use in 
finishing products for fabric, textiles, and leather; 
•Industrial and commercial use in 
automotive care products (functional fluids for air conditioners); 
•Industrial and commercial use in 
automotive care products (interior car care); 
•Industrial and commercial use in 
automotive care products (degreasers); 
•Industrial and commercial use in 
apparel and footwear care products; 
•Industrial and commercial use in 
spot removers for apparel and textiles; 
•Industrial and commercial use in 
liquid lubricants and greases; 
•Industrial and commercial use in 
spray lubricants and greases; 
•Industrial and commercial use in 
aerosol degreasers and cleaners; 
•Industrial and commercial use in 
non-aerosol degreasers and cleaners; 
•Industrial and commercial use in 
cold pipe insulations; 
•Industrial and commercial use as 
solvent that becomes part of a formulation or mixture; 
•Industrial and commercial use as a 
processing aid; 
•Industrial and commercial use as 
propellant and blowing agent; 
•Industrial and commercial use for 
electrical equipment, appliance, and component manufacturing; 
•Industrial and commercial use for 
plastic and rubber products manufacturing; 
•Industrial and commercial use for 
cellulose triacetate film production; 
•Industrial and commercial use as 
anti-spatter welding aerosol; 
•Industrial and commercial use for 
oil and gas drilling, extraction, and support activities; 
•Industrial and commercial uses for 
toys, playgrounds, and sporting equipments (including novelty articles); 
•Industrial and commercial use for 
carbon removers, wood floor cleaners, and brush cleaners; 
•Industrial and commercial use as a 
lithographic printing plate cleaner; 
•Consumer use as a solvent in an 
aerosol cleaner/degreaser; 
•Consumer use in adhesives and 
sealants; 
•Consumer use in paints and 
coatings (brush cleaners for paints and coatings); 
•Consumer use in adhesives/caulk 
removers; 
•Consumer use in aerosol and non- 
aerosol metal degreasers; 
•Consumer use in automotive 
functional fluids (air conditioners refrigerant, treatment, leak sealer); •Consumer use in automotive 
degreasers (gasket remover, 
transmission cleaners, carburetor); 
•Consumer use in aerosol and non- 
aerosol lubricants and greases, consumer use in cold pipe insulation; 
•Consumer use in aerosol and non- 
aerosol lubricants/greases and aerosol 
and non-aerosol degreaser/cleaners; 
•Consumer use in cold pipe 
insulation; 
•Consumer use in crafting glue and 
cement/concrete; 
•Consumer use in anti-adhesive 
agent—anti-spatter welding aerosol; and 
•Consumer use in carbon remover 
and brush cleaner. 
Under the proposed whole chemical 
approach to the methylene chloride risk determination, the unreasonable risk from methylene chloride would continue to be driven by risk from those same condition of use. In addition, by removing the assumption of PPE use in making the whole chemical risk determination for methylene chloride, five conditions of use in addition to the original 47 would drive the draft unreasonable risk determination: 
•Manufacturing (domestic 
manufacture); 
•Processing as a reactant; 
•Processing: recycling; 
•Industrial and commercial use as 
laboratory chemical; and 
•Disposal. 
Overall, 52 conditions of use out of 
the 53 EPA evaluated would drive the methylene chloride whole chemical unreasonable risk determination. 
III. Revision of the June 2020 Risk 
Evaluation 
A. Why is EPA proposing to revise the 
risk determination for the methylene chloride risk evaluation? 
EPA is proposing to revise the risk 
determination for the methylene chloride risk evaluation pursuant to TSCA section 6(b) and consistent with Executive Order 13990, (‘‘Protecting Public Health and the Environment and Restoring Science to Tackle the Climate Crisis’’) and other Administration priorities (Refs. 3, 4, and 6). EPA is revising specific aspects of the first ten TSCA existing chemical risk evaluations in order to ensure that the risk evaluations better align with TSCA’s objective of protecting health and the environment. For the methylene chloride risk evaluation, this includes the draft revision: (1) making the risk determination in this instance based on the whole chemical substance instead of by individual conditions of use, and (2) emphasizing that EPA does not rely on the assumed use of PPE when making the risk determination. 
VerDate Sep<11>2014 17:28 Jul 01, 2022 Jkt 256001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\05JYN1.SGM 05JYN1lotter on DSK11XQN23PROD with NOTICES139830 Federal Register / Vol. 87, No. 127 / Tuesday, July 5, 2022 / Notices 
B. What are the draft revisions? 
EPA is releasing a draft revision of the 
risk determination for the methylene 
chloride risk evaluation pursuant to TSCA section 6(b). Under the draft revised determination, EPA preliminarily concludes that methylene chloride, as evaluated in the risk evaluation as a whole, presents an unreasonable risk of injury to health under its conditions of use. This revision would replace the previous unreasonable risk determinations made for methylene chloride by individual conditions of use, supersede the determinations (and withdraw the associated order) of no unreasonable risk for the conditions of use identified in the TSCA section 6(i)(1) no unreasonable risk order, and clarify the lack of reliance on assumed use of PPE as part of the risk determination. 
These draft revisions do not alter any 
of the underlying technical or scientific information that informs the risk characterization, and as such the hazard, exposure, and risk characterization sections are not changed except to the extent that statements about PPE assumptions in section 2.4.1.1 (Consideration of Engineering Controls and PPE) of the methylene chloride risk evaluation would be superseded. The discussion of the issues in this notice and in the accompanying draft revision to the risk determination would supersede any conflicting statements in the prior executive summary and section 2.4.1.1 from the methylene chloride risk evaluation and the response to comments document (Refs. 2 and 10). Additional policy changes to other chemical risk evaluations, including any consideration of potentially exposed or susceptible subpopulations and/or inclusion of additional exposure pathways, are not necessarily reflected in these draft revisions to the risk determination. 
C. Will the draft revised risk 
determination be peer reviewed? 
The risk determination (section 5 in 
the June 2020 risk evaluation) was not part of the scope of the peer reviews of the methylene chloride risk evaluation by the Science Advisory Committee on Chemicals (SACC). Thus, consistent with that approach, EPA does not intend to conduct peer review for the draft revised unreasonable risk determination of the methylene chloride risk evaluation because no technical or scientific changes will be made to the hazard or exposure assessments or the risk characterization. D. What are the next steps for finalizing revisions to the risk determination? 
EPA will review and consider public 
comment received on the draft revised risk determination for the methylene chloride risk evaluation and, after considering those public comments, issue the revised final methylene chloride risk determination. If finalized as drafted, EPA would also issue a new order to withdraw the TSCA section 6(i)(1) no unreasonable risk order issued in Section 5.4.1 of the 2020 methylene chloride risk evaluation. This final revised risk determination would supersede the June 2020 risk determinations of no unreasonable risk. Consistent with the statutory requirements of TSCA section 6(a), the Agency would then propose risk management actions to address the unreasonable risk determined in the methylene chloride risk evaluation. 
IV. References 
The following is a listing of the 
documents that are specifically 
referenced in this document. The docket includes these documents and other information considered by EPA, including documents that are referenced within the documents that are included in the docket, even if the referenced document is not physically located in the docket. For assistance in locating these other documents, please consult the person listed under 
FOR FURTHER  
INFORMATION CONTACT . 
1. EPA. Draft Revised Unreasonable Risk 
Determination for methylene chloride, 
Section 5, July 2022. 
2. EPA. Risk Evaluation for Methylene 
Chloride (MC). EPA Document #740–R1– 
8010. January 2021. https://www.regulations.gov/document/EPA- HQ-OPPT-2019-0437-0107. 
3. Executive Order 13990. Protecting Public 
Health and the Environment and Restoring Science to Tackle the Climate Crisis. Federal Register. 86 FR 7037, 
January 25, 2021. 
4. Executive Order 13985. Advancing Racial 
Equity and Support for Underserved Communities Through the Federal Government. Federal Register. 86 FR 
7009, January 25, 2021. 
5. Executive Order 14008. Tackling the 
Climate Crisis at Home and Abroad. Federal Register. 86 FR 7619, February 1, 2021. 
6. Presidential Memorandum. Memorandum 
on Restoring Trust in Government Through Scientific Integrity and Evidence-Based Policymaking. Federal Register. 86 FR 8845, February 10, 2021. 
7. EPA Press Release. EPA Announces Path 
Forward for TSCA Chemical Risk Evaluations. June 2021. https://www.epa.gov/newsreleases/epa- announces-path-forward-tsca-chemical- risk-evaluations. 8. EPA. Proposed Rule; Procedures for 
Chemical Risk Evaluation Under the Amended Toxic Substances Control Act. Federal Register. 82 FR 7562, January 19, 2017 (FRL–9957–75). 
9. EPA. Final Rule; Procedures for Chemical 
Risk Evaluation Under the Amended Toxic Substances Control Act. Federal Register. 82 FR 33726, July 20, 2017 (FRL–9964–38). 
10. EPA. Summary of External Peer Review 
and Public Comments and Disposition for Methylene Chloride (MC); Response to Support Risk Evaluation of Methylene Chloride (MC). EPA Document# EPA– 740–R2–0022. June 2020. https://www.regulations.gov/document/EPA- HQ-OPPT-2019-0437-0083. 
11. Occupational Safety and Health 
Administration. Permissible Exposure Limits—Annotated Tables. Accessed June 13, 2022. https://www.osha.gov/ annotated-pels. 
Authority: 15 U.S.C. 2601 et seq. 
Dated: June 28, 2022. 
Michal Freedhoff, 
Assistant Administrator, Office of Chemical 
Safety and Pollution Prevention. 
[FR Doc. 2022–14163 Filed 7–1–22; 8:45 am] 
BILLING CODE 6560–50–P 
ENVIRONMENTAL PROTECTION 
AGENCY 
[EPA–HQ–OLEM–2018–0317; FRL–9905– 
01–OLEM] 
Agency Information Collection 
Activities; Proposed Collection; Comment Request; Criteria for Classification of Solid Waste Disposal Facilities and Practices (Renewal), EPA ICR No. 1745.10, OMB Control No. 2050–0154 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Notice. 
SUMMARY : The Environmental Protection 
Agency (EPA) is planning to submit the information collection request (ICR), Criteria for Classification of Solid Waste Disposal Facilities and Practices, Recordkeeping and Reporting Requirements (EPA ICR No. 1745.10, OMB Control No. 2050–0154) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act (PRA). Before doing so, the EPA is soliciting public comments on specific aspects of the proposed information collection as described in 
SUPPLEMENTARY INFORMATION . This is a 
proposed extension of the ICR, which is currently approved through February 28, 2023. An Agency may not conduct or sponsor and a person is not required to respond to a collection of information 
VerDate Sep<11>2014 17:28 Jul 01, 2022 Jkt 256001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\05JYN1.SGM 05JYN1lotter on DSK11XQN23PROD with NOTICES1